Cite
HARVARD Citation
Laquente, B. et al. (2017). A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. BMC cancer. 17 (1), pp. 1-9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Laquente, B. et al. (2017). A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. BMC cancer. 17 (1), pp. 1-9. [Online].